All Publications

Data provided by UCSF Profiles, powered by CTSI at UCSF
  1. Valencia A, Vergara C, Thio CL, Vince N, Douillard V, Grifoni A, Cox AL, Johnson EO, Kral AH, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Price JC, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Wojcik GL, Carrington M, Gourraud PA, Sette A, Thomas DL, Duggal P. Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1. Am J Hum Genet. 2022 02 03; 109(2):299-310. View in PubMed
  2. Durand CM, Florman S, Motter JD, Brown D, Ostrander D, Yu S, Liang T, Werbel WA, Cameron A, Ottmann S, Hamilton JP, Redd AD, Bowring MG, Eby Y, Fernandez RE, Doby B, Labo N, Whitby D, Miley W, Friedman-Moraco R, Turgeon N, Price JC, Chin-Hong P, Stock P, Stosor V, Kirchner VA, Pruett T, Wojciechowski D, Elias N, Wolfe C, Quinn TC, Odim J, Morsheimer M, Mehta SA, Rana MM, Huprikar S, Massie A, Tobian AAR, Segev DL, HOPE in Action Investigators. HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV. Am J Transplant. 2021 Nov 06. View in PubMed
  3. Werbel WA, Brown DM, Kusemiju OT, Doby BL, Seaman SM, Redd AD, Eby Y, Fernandez RE, Desai NM, Miller J, Bismut GA, Kirby CS, Schmidt HA, Clarke WA, Seisa M, Petropoulos CJ, Quinn TC, Florman SS, Huprikar S, Rana MM, Friedman-Moraco RJ, Mehta AK, Stock PG, Price JC, Stosor V, Mehta SG, Gilbert AJ, Elias N, Morris MI, Mehta SA, Small CB, Haidar G, Malinis M, Husson JS, Pereira MR, Gupta G, Hand J, Kirchner VA, Agarwal A, Aslam S, Blumberg EA, Wolfe CR, Myer K, Wood RP, Neidlinger N, Strell S, Shuck M, Wilkins H, Wadsworth M, Motter JD, Odim J, Segev DL, Durand CM, Tobian AAR, HOPE in Action Investigators. National Landscape of HIV+ Deceased Organ Donors in the United States. Clin Infect Dis. 2021 Aug 28. View in PubMed
  4. Moron-Lopez S, Xie G, Kim P, Siegel DA, Lee S, Wong JK, Price JC, Elnachef N, Greenblatt RM, Tien PC, Roan NR, Yukl SA. Tissue-specific differences in HIV DNA levels and mechanisms that govern HIV transcription in blood, gut, genital tract and liver in ART-treated women. J Int AIDS Soc. 2021 07; 24(7):e25738. View in PubMed
  5. Pena Dias J, Haberlen SA, Dobs AS, Lake JE, Palella FJ, Kingsley LA, Price JC, Basaria S, Varadhan R, Margolick JB, Thio CL, Brown TT. Longitudinal Changes in Sex Hormone-Binding Globulin in Men With HIV. J Acquir Immune Defic Syndr. 2021 08 15; 87(5):1178-1186. View in PubMed
  6. Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. Am J Transplant. 2021 09; 21(9):3148-3156. View in PubMed
  7. McIntosh AT, Wei R, Ahn J, Aouizerat BE, Kassaye SG, Augenbraun MH, Price JC, French AL, Gange SJ, Anastos KM, Goldman R. A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women. PLoS One. 2021; 16(3):e0247277. View in PubMed
  8. Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ, AASLD COVID-19 Vaccine Working Group. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology. 2021 08; 74(2):1049-1064. View in PubMed
  9. Kardashian A, Wilder J, Terrault NA, Price JC. Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action. Hepatology. 2021 02; 73(2):811-820. View in PubMed
  10. Lake JE, Overton T, Naggie S, Sulkowski M, Loomba R, Kleiner DE, Price JC, Chew KW, Chung RT, Corey KE. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. Clin Gastroenterol Hepatol. 2022 02; 20(2):256-268. View in PubMed
  11. Maurice JB, Goldin R, Hall A, Price JC, Sebastiani G, Morse CG, Prat LI, Perazzo H, Garvey L, Ingiliz P, Guaraldi G, Tsochatzis E, Lemoine M. Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection. Clin Infect Dis. 2021 10 05; 73(7):e2184-e2193. View in PubMed
  12. Jenny Pena Dias, Sabina Haberlen, Adrian Dobs, Jordan Lake, FranK J Palella, Lawrence Kingsley, Shehzad Sultan Basaria, Jennifer C Price, Matt Budoff, Chloe L Thio, Todd Tarquin Brown. SAT-LB134 Aging Related Changes in Sex Hormone-Binding Globulin in Men With HIV. Journal of the Endocrine Society. 2020 May 8; 4(Suppl 1). View in PubMed
  13. Price JC, Brandman D. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. JAMA Intern Med. 2020 05 01; 180(5):637-639. View in PubMed
  14. Kardashian A, Peters MG, Tien PC, Price JC. The Pathogenesis of Liver Disease in People Living With Human Immunodeficiency Virus: The Emerging Role of the Microbiome. Clin Liver Dis (Hoboken). 2020 Jan; 15(1):46-51. View in PubMed
  15. Guaraldi G, Maurice JB, Marzolini C, Monteith K, Milic J, Tsochatzis E, Bhagani S, Morse CG, Price JC, Ingiliz P, Lemoine M, Sebastiani G, SHIVER Network. New Drugs for NASH and HIV Infection: Great Expectations for a Great Need. Hepatology. 2020 05; 71(5):1831-1844. View in PubMed
  16. Price JC, Bhattacharya D. Editorial: HBV-the promise of a new era in therapeutics. Aliment Pharmacol Ther. 2020 02; 51(4):479-480. View in PubMed
  17. Tien PC, Duarte M, Roque A, Price J. MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One? Dig Dis Sci. 2020 04; 65(4):928-930. View in PubMed
  18. S. Moron-Lopez, G. Xie, P. Kim, J. Wong, J. Price, N. Elnachef, R. Greenblatt, P. Tien, N. Roan, S. Yukl. OP 7.6 Tissue-specific differences in the mechanisms that govern HIV latency in blood, liver, gut and genital tract in ART-suppressed women. Journal of virus eradication. 2019 Dec 1; 5:40. View in PubMed
  19. Kaplan, A. Price, J.C.. HIV-Associated NAFLD: Disease Burden and Management. Curr Hepatology Rep. 2019; (18):482-491. View in PubMed
  20. Jennifer C Price, Ruibin Wang, Eric C Seaberg, Todd T Brown, Matthew J Budoff, Lawrence A Kingsley, Frank J Palella, Mallory D Witt, Wendy S Post, Jordan E Lake, Chloe L Thio. Sex hormone-binding globulin levels are inversely associated with nonalcoholic fatty liver disease in HIV-infected and –uninfected men. Open Forum Infectious Diseases. 2019 Nov 6. View in PubMed
  21. Price JC, Wang R, Seaberg EC, Brown TT, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Lake JE, Thio CL. Sex Hormone-Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men. Open Forum Infect Dis. 2019 Dec; 6(12):ofz468. View in PubMed
  22. Durand CM, Werbel W, Doby B, Brown D, Desai NM, Malinis M, Price J, Chin-Hong P, Mehta S, Friedman-Moraco R, Turgeon NA, Gilbert A, Morris MI, Stosor V, Elias N, Aslam S, Santos CAQ, Hand JM, Husson J, Pruett TL, Agarwal A, Adebiyi O, Pereira M, Small CB, Apewokin S, Heun Lee D, Haidar G, Blumberg E, Mehta SA, Huprikar S, Florman SS, Redd AD, Tobian AAR, Segev DL. Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results. Am J Transplant. 2020 02; 20(2):617-619. View in PubMed
  23. Golovaty I, Tien PC, Price JC, Sheira L, Seligman H, Weiser SD. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. J Nutr. 2020 01 01; 150(1):91-98. View in PubMed
  24. Cedarbaum E, Ma Y, Scherzer R, Price JC, Adimora AA, Bamman M, Cohen M, Fischl MA, Matsushita K, Ofotokun I, Plankey M, Seaberg EC, Yin MT, Grunfeld C, Vartanian S, Sharma A, Tien PC. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women. AIDS. 2019 11 01; 33(13):2025-2033. View in PubMed
  25. Kardashian A, Ma Y, Yin MT, Scherzer R, Nolan O, Aweeka F, Tien PC, Price JC. High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus-Coinfected Women. Open Forum Infect Dis. 2019 Jul; 6(7):ofz281. View in PubMed
  26. Ani Kardashian, Yifei Ma, Michael T. Yin, Rebecca Scherzer, Olivia Nolan, Francesca Aweeka, Phyllis Tien, Jennifer Price. Su1080 – High Kynurenine:Tryptophan Ratio is Associated with Liver Fibrosis in Hiv Infection. Gastroenterology. 2019 May 1; 156(6):s-1269. View in PubMed
  27. Ani Kardashian, Yifei Ma, Michael T. Yin, Rebecca Scherzer, Olivia Nolan, Francesca Aweeka, Phyllis Tien, Jennifer Price. Su1080 – High Kynurenine:Tryptophan Ratio is Associated with Liver Fibrosis in Hiv Infection. . 2019 May 1; 156(6):s-1269. View in PubMed
  28. Price JC, McKinney JE, Crouch PC, Dillon SM, Radix A, Stivala A, Carollo JR, Fierer DS. Sexually Acquired Hepatitis C Infection in HIV-Uninfected Men Who Have Sex With Men Using Preexposure Prophylaxis Against HIV. J Infect Dis. 2019 04 16; 219(9):1373-1376. View in PubMed
  29. Price JC, Seaberg EC, Stosor V, Witt MD, Lellock CD, Thio CL. Aspartate aminotransferase-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men. AIDS. 2018 11 13; 32(17):2636-2638. View in PubMed
  30. Kardashian A, McKinney J, Huynh N, Yu R, Peters M, Catalli L, Price JC. Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing Therapy. Clin Infect Dis. 2019 05 02; 68(10):1784-1787. View in PubMed
  31. Mellor-Crummey LE, Lake JE, Wilhalme H, Tseng CH, Grant PM, Erlandson KM, Price JC, Palella FJ, Kingsley LA, Budoff M, Post WS, Brown TT. A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus. J Clin Gastroenterol Hepatol. 2018; 2(3). View in PubMed
  32. J. Price, R. Wang, E. Seaberg, T. Brown, M. Budoff, L. Kingsley, F.P. Jr, M. Witt, W. Post, J. Lake, C. Thio. SAT-523 Sex hormone binding globulin levels are increased in HIV-infected men and are independently associated with lower odds of nonalcoholic fatty liver disease regardless of HIV serostatus. Journal of Hepatology. 2018 Apr 1; 68:s840. View in PubMed
  33. J. Price, R. Wang, E. Seaberg, T. Brown, M. Budoff, L. Kingsley, F.P. Jr, M. Witt, W. Post, J. Lake, C. Thio. SAT-523 Sex hormone binding globulin levels are increased in HIV-infected men and are independently associated with lower odds of nonalcoholic fatty liver disease regardless of HIV serostatus. . 2018 Apr 1; 68:s840. View in PubMed
  34. Reid M, Ma Y, Scherzer R, Price JC, French AL, Huhn GD, Plankey MW, Peters M, Grunfeld C, Tien PC. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus. J Infect Dis. 2018 03 28; 217(8):1289-1297. View in PubMed
  35. Mellor-Crummey LE, Lake JE, Wilhalme H, Tseng CH, Grant PM, Erlandson KM, Price JC, Palella Jr FJ, Kingsley LA, Budoff M, Post WS, Brown TT. A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus. J Clin Gastroenterol Hepatol. 2018; 2:No.3:16 doi: 10.21767/2575-773. View in PubMed
  36. Reid M, Price JC, Tien PC. Hepatitis C Virus Infection in the Older Patient. Infect Dis Clin North Am. 2017 12; 31(4):827-838. View in PubMed
  37. Price JC, Tien PC. Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression? Am J Gastroenterol. 2017 Oct; 112(10):1506-1507. View in PubMed
  38. Price JC, Dodge JL, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski S, Tien PC. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults. AIDS. 2017 09 24; 31(15):2119-2125. View in PubMed
  39. Price JC, Wang R, Seaberg EC, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. Open Forum Infect Dis. 2017; 4(3):ofx153. View in PubMed
  40. Price JC, Tien PC. Reply. Hepatology. 2017 08; 66(2):674-675. View in PubMed
  41. Price JC, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection. Hepatology. 2017 03; 65(3):853-863. View in PubMed
  42. Kardashian A, Ma Y, Scherzer R, Price JC, Sarkar M, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Sex differences in the association of HIV infection with hepatic steatosis. AIDS. 2017 01 28; 31(3):365-373. View in PubMed
  43. Reid M, Ma Y, Scherzer R, Price JC, French AL, Plankey MW, Grunfeld C, Tien PC. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults. AIDS. 2017 01 28; 31(3):385-393. View in PubMed
  44. Park L, Mone A, Price JC, Tzimas D, Hirsh J, Poles MA, Malter L, Chen LA. Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance. Ann Gastroenterol. 2017; 30(1):83-88. View in PubMed
  45. Jennifer Price, Jennifer Dodge, Yifei Ma, Rebecca Scherzer, Natalie Korn, Kyle Tillinghast, Marion Peters, Sue Noworolski, Phyllis Tien. Correlation of Controlled Attenuation Parameter and Magnetic Resonance Spectroscopy Measurements of Hepatic Steatosis in HIV-positive Adults. The American Journal of Gastroenterology. 2016 Oct 1; 111:s371. View in PubMed
  46. Konerman MA, Price JC, Campbell CY, Eluri S, Gurakar A, Hamilton J, Li Z. Pre-Liver Transplant Transthoracic Echocardiogram Findings and 6-Month Post-Transplant Outcomes: A Case-Control Analysis. Ann Transplant. 2016 Jul 05; 21:416-27. View in PubMed
  47. Price JC, Seaberg EC, Phair JP, Witt MD, Koletar SL, Thio CL. Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. J Acquir Immune Defic Syndr. 2016 07 01; 72(3):319-23. View in PubMed
  48. Kardashian AA, Price JC. Hepatitis C virus-HIV-coinfected patients and liver transplantation. Curr Opin Organ Transplant. 2015 Jun; 20(3):276-85. View in PubMed
  49. Price JC, Terrault NA. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in. Liver Transpl. 2015 Apr; 21(4):423-34. View in PubMed
  50. Price JC, Terrault NA. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective. Liver Int. 2015 Jan; 35(1):7-8. View in PubMed
  51. Konerman MA, Price J, Torres D, Li Z. Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methods. Therap Adv Gastroenterol. 2014 Sep; 7(5):184-92. View in PubMed
  52. Price JC, Murphy RC, Shvachko VA, Pauly MP, Manos MM. Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting. Dig Dis Sci. 2014 Dec; 59(12):3043-52. View in PubMed
  53. Chen T, Hubbard A, Murtazina R, Price J, Yang J, Cha B, Sarker R, Donowitz M. Myosin VI mediates the movement of NHE3 down the microvillus in intestinal epithelial cells. J Cell Sci. 2014 Aug 15; 127(Pt 16):3535-45. View in PubMed
  54. Price JC, Seaberg EC, Latanich R, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. Risk factors for fatty liver in the Multicenter AIDS Cohort Study. Am J Gastroenterol. 2014 May; 109(5):695-704. View in PubMed
  55. Jodorkovsky D, Price JC, Kim B, Dhalla S, Stein EM, Clarke JO. Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms. Dig Dis Sci. 2014 Aug; 59(8):1817-22. View in PubMed
  56. Price J. An update on hepatitis B, D, and E viruses. Top Antivir Med. 2014 Jan; 21(5):157-63. View in PubMed
  57. Jennifer C. Price. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation. Current Hepatology Reports. 2013 Dec 1; 12(4):227-235. View in PubMed
  58. Jennifer Price, Valentina Shvachko, Rosemary Murphy, Michele M. Manos. Characteristics of HCV Direct Acting Antiviral Treatment Initiators in a Large Integrated Care Setting. The American Journal of Gastroenterology. 2013 Oct 1; 108:s151. View in PubMed
  59. Jennifer Price, Eric Seaberg, Anand Mehta, Sheila Badri, Mallory Witt, Kristin D'Acunto, Chloe Thio. Non-invasive Liver Fibrosis Markers Are Associated with Liver-Related Death in the Multicenter AIDS Cohort Study. The American Journal of Gastroenterology. 2013 Oct 1; 108:s153. View in PubMed
  60. Gulsen MT, Girotra M, Cengiz-Seval G, Price J, Singh VK, Segev DL, Cameron AM, Gurakar A. HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant. 2013 Feb 20; 18:69-75. View in PubMed
  61. Price JC. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation. Current Hepatitis Reports. 2013; 12(4):227-235. View in PubMed
  62. Price J, Thio C. Reply to Post and Sabin. J Infect Dis. 2013 Jan 15; 207(2):368-9. View in PubMed
  63. Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis. 2012 Mar 15; 205(6):1005-13. View in PubMed
  64. Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1002-12. View in PubMed
  65. Liang DB, Price JC, Ahmed H, Farmer N, Montgomery EA, Giday SA. Gastric sarcoidosis: case report and literature review. J Natl Med Assoc. 2010 Apr; 102(4):348-51. View in PubMed
  66. Price J and Li Z. . Hepatitis B- Recent Developments in Therapy. European Gastroenterology & Hepatology Review. 2009; 5(1):38-42. View in PubMed
  67. O'Toole TP, Conde-Martel A, Young JH, Price J, Bigelow G, Ford DE. Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes. J Gen Intern Med. 2006 Jun; 21(6):570-6. View in PubMed
  68. Miller RG, Ashar BH, Cohen J, Camp M, Coombs C, Johnson E, Schneyer CR. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005 Sep; 20(9):847-51. View in PubMed
  69. Cohen JG, Dryja TP, Davis KB, Diller LR, Li FP. RB1 genetic testing as a clinical service: a follow-up study. Med Pediatr Oncol. 2001 Oct; 37(4):372-8. View in PubMed